AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹368 Cr | ₹311 Cr | ₹159 Cr | ₹158 Cr | ₹141 Cr |
What is the latest Contingent Liabilities ratio of AUROBINDO PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹368 Cr |
| Mar2024 | ₹311 Cr |
| Mar2023 | ₹159 Cr |
| Mar2022 | ₹158 Cr |
| Mar2021 | ₹141 Cr |
How is Contingent Liabilities of AUROBINDO PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹368 Cr | 18.28 | |
| Mar2024 | ₹311 Cr | 96.39 | |
| Mar2023 | ₹159 Cr | 0.50 | |
| Mar2022 | ₹158 Cr | 12.01 | |
| Mar2021 | ₹141 Cr | - | |
Compare Contingent Liabilities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹89,471.8 Cr | 3.8% | 6.2% | 41.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 3.8% |
6.2% |
41.2% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses